We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
CAPLIPOINT.NSE

Price
1713.80
Stock movement down
-149.45 (-8.02%)
Company name
Caplin Point Laboratories Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
130.27B
Ent value
132.00B
Price/Sales
7.37
Price/Book
5.06
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
26.39
Forward P/E
-
PEG
-
EPS growth
20.79%
1 year return
33.80%
3 year return
34.54%
5 year return
43.28%
10 year return
31.33%
Last updated: 2025-04-11

DIVIDENDS

CAPLIPOINT.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E26.39
Price to OCF468.59
Price to FCF468.59
Price to EBITDA81.68
EV to EBITDA82.77

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales7.37
Price to Book5.06
EV to Sales7.47

FINANCIALS

Per share

Per share data
Current share count76.01M
EPS (TTM)64.60
FCF per share (TTM)3.64

Income statement

Income statement data
Revenue (TTM)17.67B
Gross profit (TTM)9.70B
Operating income (TTM)6.21B
Net income (TTM)4.94B
EPS (TTM)64.60
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)54.88%
Operating margin (TTM)35.12%
Profit margin (TTM)27.93%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash1.77B
Net receivables0.00
Total current assets19.99B
Goodwill0.00
Intangible assets116.70M
Property, plant and equipment0.00
Total assets29.24B
Accounts payable2.14B
Short/Current long term debt24.30M
Total current liabilities3.29B
Total liabilities3.50B
Shareholder's equity25.75B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)278.00M
Capital expenditures (TTM)0.00
Free cash flow (TTM)278.00M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity19.17%
Return on Assets16.88%
Return on Invested Capital19.16%
Cash Return on Invested Capital1.08%

STOCK INFORMATION

Stock chart

Stock price data
Open1856.85
Daily high1856.85
Daily low1701.55
Daily Volume300K
All-time high2600.15
1y analyst estimate2348.33
Beta0.40
EPS (TTM)64.60
Dividend per share-
Ex-div date23 Sep 2024
Next earnings date-

Downside potential

Downside potential data
CAPLIPOINT.NSES&P500
Current price drop from All-time high-34.09%-10.49%
Highest price drop-74.55%-56.47%
Date of highest drop24 Mar 20209 Mar 2009
Avg drop from high-24.16%-11.07%
Avg time to new high24 days12 days
Max time to new high980 days1805 days
COMPANY DETAILS
CAPLIPOINT.NSE (Caplin Point Laboratories Limited) company logo
Marketcap
130.27B
Marketcap category
Large-cap
Description
Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.
Employees
3406
Website
https://www.caplinpoint.net
Investor relations
-
SEC filings
CAPLIPOINT.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved